Page last updated: 2024-12-05

streptonigrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5298
CHEMBL ID11417
CHEBI ID9287
SCHEMBL ID3940
SCHEMBL ID1650605
SCHEMBL ID17111078
MeSH IDM0020597

Synonyms (107)

Synonym
rufochromomycin
ao50165l302
streptonigran
nsc 45383
abbott crystalline antibiotic
picolinic acid,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-
nsc-45383
5-amino-6-(7-amino-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpicolinic acid
mls000766205 ,
5278 r. p.
2-pyridinecarboxylic acid,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-
picolinic acid,8-dihydro-7-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-
wln: t66 bv ev gnj co1 dz h- bt6nj cz dr bq co1 do1& e1 fvq
antibiotic from streptomyces flocculus
NCI60_041843
NCIMECH_000191
NCI60_004051
smr000058748
MLS000028827 ,
nsc56748
nsc-56748
mls000766219 ,
nsc-83950
rufocromomycin (inn)
D05931
streptonigrin (usan)
nigrin (tn)
SMP2_000320
rufocromomycine
brn 0599390
valacidin
rufocromomycine [inn-french]
ai3-52152
2-pyridinecarboxylic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-
5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpicolinic acid
rufocromomicina [inn-spanish]
sn (van)
rufocromomycinum [inn-latin]
einecs 223-501-8
streptonigrin [usan]
ccris 1264
nsc 83950
5-amino-6-(7-amino-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxy-phenyl)-3-methyl-pyridine-2-carboxylic acid
nigrin
rufocromomycin
NSC83950 ,
NSC45383 ,
a 050165l302
picolinic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-
bruneomycin
3930-19-6
streptonigrin ,
C02081
streptonigrin from streptomyces flocculus, >=98%
(4e)-5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(4,5-dimethoxy-6-oxo-1-cyclohexa-2,4-dienylidene)-3-methyl-1h-pyridine-2-carboxylic acid
CHEMBL11417
rufocromomycinum
CHEBI:9287 ,
rufocromomicina
5-amino-6-(7-amino-6-methoxy-5,8-dioxo-5,8-dihydroquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid
(4z)-5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(4,5-dimethoxy-6-oxocyclohexa-2,4-dien-1-ylidene)-3-methyl-1h-pyridine-2-carboxylic acid
(4e)-5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(4,5-dimethoxy-6-oxocyclohexa-2,4-dien-1-ylidene)-3-methyl-1h-pyridine-2-carboxylic acid
NCGC00247058-01
HMS2230J24
sr-01000721857
SR-01000721857-5
CCG-35398
CCG-36481
unii-261q3jb310
5-25-17-00308 (beilstein handbook reference)
5278 r.p.
261q3jb310 ,
rufocromomycin [inn]
streptonigrin from streptomyces flocculus
bdbm50447758
streptonigrin [mi]
antibiotic produced by streptomyces flocculus
rufocromomycin [who-dd]
smr003365494
MLS004556149
SCHEMBL3940
SCHEMBL1650605
(4e)-5-azanyl-6-[7-azanyl-6-methoxy-5,8-bis(oxidanylidene)quinolin-2-yl]-4-(4,5-dimethoxy-6-oxidanylidene-cyclohexa-2,4-dien-1-ylidene)-3-methyl-1h-pyridine-2-carboxylic acid
cid_5323583
(4e)-5-amino-6-(7-amino-5,8-diketo-6-methoxy-2-quinolyl)-4-(6-keto-4,5-dimethoxy-cyclohexa-2,4-dien-1-ylidene)-3-methyl-1h-pyridine-2-carboxylic acid
bdbm34650
(4e)-5-amino-6-(7-amino-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(4,5-dimethoxy-6-oxo-1-cyclohexa-2,4-dienylidene)-3-methyl-1h-pyridine-2-carboxylic acid
2-pyridinecarboxylic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-, (4r)-
(r)-streptonigrin
5-amino-6-(7-amino-6-methoxy-5,8-dioxo-5,8-dihydro-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-2-pyridinecarboxylic acid #
PVYJZLYGTZKPJE-UHFFFAOYSA-N
gtpl8683
OPERA_ID_823
SCHEMBL17111078
SR-01000721857-3
streptonigrin (racemate)
1079893-79-0 (racemate)
3930-19-6 (r-isomer)
Q15427845
HY-124586
CS-0087029
5-amino-6-(7-amino-6-methoxy-5,8-dioxo-5,8-dihydroquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpicolinic acid
1079893-79-0
DTXSID00960034
5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid
2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-
AKOS040742654

Research Excerpts

Overview

Streptonigrin (STN, 1) is a highly functionalized aminoquinone alkaloid with broad and potent antitumor activity. At low doses it produces DNA strand breaks leading to decreased colony-forming ability and decreased rates of DNA synthesis.

ExcerptReferenceRelevance
"Streptonigrin is an aminoquinone alkaloid isolated from "( Chemistry, Biosynthesis and Pharmacology of Streptonigrin: An Old Molecule with Future Prospects for New Drug Design, Development and Therapy.
Begum, MY; Chidambaram, K; Chinna Maruthu, SK; Djearamane, S; Fuloria, NK; Fuloria, S; Gan, SH; Lum, PT; Mat Rani, NNI; Nabihah Nasir, N; Ramar, M; Ravi, S; Safi, SZ; Sekar, M; Selvaraj, S; Sisinthy, SP; Subramaniyan, V; Wong, LS, 2023
)
2.61
"Streptonigrin (STN, 1) is a highly functionalized aminoquinone alkaloid antibiotic with broad and potent antitumor activity. "( StnK2 catalysing a Pictet-Spengler reaction involved in the biosynthesis of the antitumor reagent streptonigrin.
Deng, Z; Huang, T; Kong, D; Lin, S; Wang, X, 2018
)
2.14
"Streptonigrin is a potent antitumor antibiotic, active against a wide range of mammalian tumor cells. "( Identification of (2S,3S)-β-Methyltryptophan as the Real Biosynthetic Intermediate of Antitumor Agent Streptonigrin.
Brock, NL; Deng, Z; Kong, D; Lin, S; Xu, F; Zhang, L; Zhang, Z; Zou, Y, 2016
)
2.09
"Streptonigrin is a negative regulator of β-catenin/Tcf signaling, and their inhibitory mechanism is related to the proliferation inhibitory effect on β-catenin-activated cancer cells."( Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells.
Chun, S; Park, S, 2011
)
3.25
"Streptonigrin (STN, 1) is a highly functionalized aminoquinone alkaloid with broad and potent antitumor activity. "( Characterization of streptonigrin biosynthesis reveals a cryptic carboxyl methylation and an unusual oxidative cleavage of a N-C bond.
Cheng, H; Deng, Z; Han, M; He, X; Kong, D; Lin, S; Tao, M; Wang, P; Xie, X; Xu, F; Zhang, L; Zhang, Z, 2013
)
2.16
"Streptonigrin is an antitumour antibiotic, which at low doses produces DNA strand breaks in cultured cells leading, e.g., to decreased colony-forming ability and decreased rates of DNA synthesis. "( Unscheduled DNA synthesis induced by streptonigrin in ataxia telangiectasia fibroblasts.
Laher, HB; Morgan, GR; Taylor, AM, 1985
)
1.98

Actions

ExcerptReferenceRelevance
"Streptonigrin was found to inhibit the interaction of TCF4 with TWIST1 in a dose-dependent manner. "( Streptonigrin Mitigates Lung Cancer-induced Cachexia by Suppressing TCF4/TWIST1-induced PTHLH Expression.
Fang, XQ; Han, GE; Kim, YS; Lee, S; Lim, CH; Lim, JH, 2023
)
3.8

Toxicity

ExcerptReferenceRelevance
" In cytotoxicity studies, SN was much more toxic to the DTD-rich HT-29 cells than to the DTD-deficient BE cells."( Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin.
Beall, HD; Bolton, EM; Gibson, NW; Liu, Y; Ross, D; Siegel, D, 1996
)
0.51
" The best substrates for NQO1 were also the most selectively toxic to the NQO1-rich BE-NQ cells compared to NQO1-deficient BE-WT cells with 37 as the most selective."( Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1.
Beall, HD; Behforouz, M; Cai, W; Ebrahimian, GR; Gerdes, JM; Hassani, M; Holley, DC; Lineswala, JP; Maharjan, BR; Marvin, CC; Mohammadi, F; Seradj, H; Stocksdale, MG, 2005
)
0.33
" Metabolism and toxicity studies demonstrated that the best substrates for NQO1 were also the most selectively toxic to NQO1-rich tumor cells compared to NQO1-deficient tumor cells."( Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.
Beall, HD; Behforouz, M; Cai, W; Charkhzarrin, S; Eads, TJ; Hassani, M; Hermann, NG; Karki, R; Koelsch, KH; Lineswala, JP; Lucas, JS; Mirzaei, H; Olang, F; Rose, AS; Sedighi, M; Seradj, H; Walter, ED; York, JS, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" In this case the resistance level may be estimated by the slope of the dose-response curve."( [Study using the probit-analysis method of the process of increasing resistance to dipin and bruneomycin in Fisher L-5178 lymphadenosis cells in experiments on animals].
Averbukh, LA, 1976
)
0.26
" First division cells analyzed 18 h after the end of treatment showed a combination of chromosome and chromatid aberrations with a typical dose-response curve."( The kinetics of chromosome and DNA damage by streptonigrin in CHO cells.
Bianchi, MS; Bianchi, NO; Testoni, MI, 1995
)
0.55
" However, increased dosage of TEL1 rescues sensitivity of a mec1 mutant, mec1-1, to DNA-damaging agents and rescues viability of a mec1 disruption."( TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1.
Collins, FS; Hieter, P; Morrow, DM; Shiloh, Y; Tagle, DA, 1995
)
0.29
" To date, the kinetics of induction and dose-response relationships of reciprocal translocations induced by chemicals have been little investigated."( Application of chromosome painting to clastogenicity testing in vitro.
Marshall, R; Obe, G, 1998
)
0.3
" Data obtained suggest a threshold for NQO1-induced toxicity above 23 nmol/min/mg and a sharp dose-response curve between the no effect level of NQO1 (23 nmol/min/mg) and the maximal effect level (>77 nmol/min/mg)."( Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.
Butler, J; Dehn, DL; Hargreaves, RH; Moody, CJ; Ross, D; Swann, E; Winski, SL, 2001
)
0.31
" Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds."( High-content single-cell drug screening with phosphospecific flow cytometry.
Clutter, MR; Crane, JM; Krutzik, PO; Nolan, GP, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
quinolone
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (63)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency0.31550.140911.194039.8107AID2451
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency89.12510.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency14.12540.177814.390939.8107AID2147
WRNHomo sapiens (human)Potency22.38720.168331.2583100.0000AID651768
phosphopantetheinyl transferaseBacillus subtilisPotency3.54810.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency1.12710.004110.890331.5287AID504467; AID624247; AID624248; AID624249; AID624250; AID624251; AID624252
USP1 protein, partialHomo sapiens (human)Potency11.22020.031637.5844354.8130AID743255
TDP1 proteinHomo sapiens (human)Potency0.07220.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency14.21910.180013.557439.8107AID1460; AID1468
Smad3Homo sapiens (human)Potency0.28180.00527.809829.0929AID588855
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency39.81070.707912.194339.8107AID720542
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency1.00000.28189.721235.4813AID2326
67.9K proteinVaccinia virusPotency0.66940.00018.4406100.0000AID720579; AID720580
IDH1Homo sapiens (human)Potency0.00920.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency1.25890.035520.977089.1251AID504332
serine-protein kinase ATM isoform aHomo sapiens (human)Potency5.98220.707925.111941.2351AID485349; AID493201; AID493218
Bloom syndrome protein isoform 1Homo sapiens (human)Potency3.54810.540617.639296.1227AID2528
galactokinaseHomo sapiens (human)Potency5.12240.943115.289453.0367AID1868; AID2015
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency0.56230.01262.451825.0177AID485313
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency14.12540.354828.065989.1251AID504847
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency0.07310.00419.984825.9290AID504444
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency0.76673.548119.542744.6684AID743266
importin subunit beta-1 isoform 1Homo sapiens (human)Potency35.48135.804836.130665.1308AID540263
DNA polymerase betaHomo sapiens (human)Potency10.00000.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency1.00000.039816.784239.8107AID1454
flap endonuclease 1Homo sapiens (human)Potency3.98110.133725.412989.1251AID588795
ras-related protein Rab-9AHomo sapiens (human)Potency0.44670.00022.621531.4954AID485297
snurportin-1Homo sapiens (human)Potency35.48135.804836.130665.1308AID540263
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency3.54810.010323.856763.0957AID2662
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency2.81840.425612.059128.1838AID504891
DNA polymerase eta isoform 1Homo sapiens (human)Potency3.54810.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency0.89130.050127.073689.1251AID588590
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency18.25630.00798.23321,122.0200AID2546; AID2551
lethal(3)malignant brain tumor-like protein 1 isoform IHomo sapiens (human)Potency19.95260.075215.225339.8107AID485360
gemininHomo sapiens (human)Potency0.56390.004611.374133.4983AID624296; AID624297
DNA polymerase kappa isoform 1Homo sapiens (human)Potency50.11870.031622.3146100.0000AID588579
survival motor neuron protein isoform dHomo sapiens (human)Potency0.31620.125912.234435.4813AID1458
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency17.78280.00419.962528.1838AID2675
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency5.01190.251215.843239.8107AID504327
lamin isoform A-delta10Homo sapiens (human)Potency0.12590.891312.067628.1838AID1487
Adenosine receptor A1Rattus norvegicus (Norway rat)Potency8.91250.06314.137115.8489AID1868
Guanine nucleotide-binding protein GHomo sapiens (human)Potency28.18381.995325.532750.1187AID624288
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency14.12541.000010.475628.1838AID1457
TAR DNA-binding protein 43Homo sapiens (human)Potency7.07951.778316.208135.4813AID652104
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency25.11890.07578.474229.0628AID602233
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency19.01150.060110.745337.9330AID485367
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
MPI proteinHomo sapiens (human)IC50 (µMol)50.00000.190013.825650.1000AID1220
protein-arginine deiminase type-4Homo sapiens (human)IC50 (µMol)2.50002.50002.50002.5000AID492970
VifHuman immunodeficiency virus 1IC50 (µMol)10.82000.270034.0015100.0000AID1117319
TatHuman immunodeficiency virus 1IC50 (µMol)42.12900.996039.8009100.0000AID1117361
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)IC50 (µMol)10.82000.270026.3638100.0000AID1117319
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)IC50 (µMol)1.87000.00001.068010.0000AID1813075
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)IC50 (µMol)1.87000.00001.104010.0000AID1813075
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)IC50 (µMol)1.87000.00001.465110.0000AID1813075
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)IC50 (µMol)1.87000.00001.146310.0000AID1813075
Sentrin-specific protease 6Homo sapiens (human)IC50 (µMol)5.20005.20005.20005.2000AID1859340
Sentrin-specific protease 2Homo sapiens (human)IC50 (µMol)6.90006.90006.90006.9000AID1859339
Sentrin-specific protease 1Homo sapiens (human)IC50 (µMol)0.52000.00642.64466.1000AID1859338; AID1868247
Protein-arginine deiminase type-3Homo sapiens (human)IC50 (µMol)0.43000.43000.43000.4300AID1069620
Protein-arginine deiminase type-4Homo sapiens (human)IC50 (µMol)2.50002.50004.20005.9000AID1069619
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (92)

Processvia Protein(s)Taxonomy
cAMP catabolic processcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
signal transductioncAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
G protein-coupled receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
sensory perception of smellcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
regulation of protein kinase A signalingcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
cellular response to xenobiotic stimuluscAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
cAMP-mediated signalingcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
neutrophil homeostasiscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP catabolic processcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
neutrophil chemotaxiscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
positive regulation of type II interferon productioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
positive regulation of interleukin-2 productioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
T cell receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
leukocyte migrationcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to lipopolysaccharidecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to xenobiotic stimuluscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to epinephrine stimuluscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
regulation of cardiac muscle cell contractioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
negative regulation of relaxation of cardiac musclecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
regulation of calcium ion transmembrane transport via high voltage-gated calcium channelcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP-mediated signalingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP catabolic processcAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
cAMP-mediated signalingcAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
regulation of heart ratecAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
cAMP catabolic processcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
positive regulation of heart ratecAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
positive regulation of type II interferon productioncAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
positive regulation of interleukin-2 productioncAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
positive regulation of interleukin-5 productioncAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
negative regulation of peptidyl-serine phosphorylationcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
negative regulation of heart contractioncAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
T cell receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
establishment of endothelial barriercAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
adrenergic receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
regulation of cardiac muscle cell contractioncAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
regulation of cell communication by electrical coupling involved in cardiac conductioncAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
negative regulation of relaxation of cardiac musclecAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
regulation of calcium ion transmembrane transport via high voltage-gated calcium channelcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
cAMP-mediated signalingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
DNA repairDNA repair and recombination protein RAD54-likeHomo sapiens (human)
DNA recombinationDNA repair and recombination protein RAD54-likeHomo sapiens (human)
chromatin remodelingDNA repair and recombination protein RAD54-likeHomo sapiens (human)
determination of adult lifespanDNA repair and recombination protein RAD54-likeHomo sapiens (human)
response to xenobiotic stimulusDNA repair and recombination protein RAD54-likeHomo sapiens (human)
response to ionizing radiationDNA repair and recombination protein RAD54-likeHomo sapiens (human)
chromosome organizationDNA repair and recombination protein RAD54-likeHomo sapiens (human)
meiotic cell cycleDNA repair and recombination protein RAD54-likeHomo sapiens (human)
double-strand break repair via synthesis-dependent strand annealingDNA repair and recombination protein RAD54-likeHomo sapiens (human)
reciprocal meiotic recombinationDNA repair and recombination protein RAD54-likeHomo sapiens (human)
proteolysisSentrin-specific protease 6Homo sapiens (human)
protein sumoylationSentrin-specific protease 6Homo sapiens (human)
protein desumoylationSentrin-specific protease 6Homo sapiens (human)
protein modification by small protein removalSentrin-specific protease 6Homo sapiens (human)
regulation of spindle assemblySentrin-specific protease 6Homo sapiens (human)
regulation of kinetochore assemblySentrin-specific protease 6Homo sapiens (human)
proteolysisSentrin-specific protease 2Homo sapiens (human)
protein transportSentrin-specific protease 2Homo sapiens (human)
Wnt signaling pathwaySentrin-specific protease 2Homo sapiens (human)
protein sumoylationSentrin-specific protease 2Homo sapiens (human)
protein desumoylationSentrin-specific protease 2Homo sapiens (human)
regulation of Wnt signaling pathwaySentrin-specific protease 2Homo sapiens (human)
negative regulation of protein ubiquitinationSentrin-specific protease 2Homo sapiens (human)
positive regulation of protein ubiquitinationSentrin-specific protease 2Homo sapiens (human)
protein destabilizationSentrin-specific protease 2Homo sapiens (human)
fat cell differentiationSentrin-specific protease 2Homo sapiens (human)
mRNA transportSentrin-specific protease 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISentrin-specific protease 1Homo sapiens (human)
proteolysisSentrin-specific protease 1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processSentrin-specific protease 1Homo sapiens (human)
protein sumoylationSentrin-specific protease 1Homo sapiens (human)
protein desumoylationSentrin-specific protease 1Homo sapiens (human)
regulation of mRNA stabilitySentrin-specific protease 1Homo sapiens (human)
apoptotic signaling pathwaySentrin-specific protease 1Homo sapiens (human)
chromatin organizationProtein-arginine deiminase type-4Homo sapiens (human)
nucleosome assemblyProtein-arginine deiminase type-4Homo sapiens (human)
chromatin remodelingProtein-arginine deiminase type-4Homo sapiens (human)
stem cell population maintenanceProtein-arginine deiminase type-4Homo sapiens (human)
protein modification processProtein-arginine deiminase type-4Homo sapiens (human)
post-translational protein modificationProtein-arginine deiminase type-4Homo sapiens (human)
innate immune responseProtein-arginine deiminase type-4Homo sapiens (human)
substantia nigra developmentProtein-arginine deiminase type-2Homo sapiens (human)
intracellular estrogen receptor signaling pathwayProtein-arginine deiminase type-2Homo sapiens (human)
transcription initiation-coupled chromatin remodelingProtein-arginine deiminase type-2Homo sapiens (human)
negative regulation of chemokine-mediated signaling pathwayProtein-arginine deiminase type-2Homo sapiens (human)
negative regulation of lymphocyte chemotaxisProtein-arginine deiminase type-2Homo sapiens (human)
cellular response to leukemia inhibitory factorProtein-arginine deiminase type-2Homo sapiens (human)
chromatin remodelingProtein-arginine deiminase type-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (44)

Processvia Protein(s)Taxonomy
3',5'-cyclic-AMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
protein bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
cAMP bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
metal ion bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
3',5'-cyclic-GMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
3',5'-cyclic-AMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
calcium channel regulator activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
protein bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
gamma-tubulin bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
transmembrane transporter bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
metal ion bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
3',5'-cyclic-GMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
3',5'-cyclic-AMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
metal ion bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
3',5'-cyclic-GMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
3',5'-cyclic-nucleotide phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
3',5'-cyclic-AMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
calcium channel regulator activitycAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
protein bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
enzyme bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
signaling receptor regulator activitycAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
cAMP bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
beta-2 adrenergic receptor bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
transmembrane transporter bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
metal ion bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
ATPase bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
scaffold protein bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
heterocyclic compound bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
3',5'-cyclic-GMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
helicase activityDNA repair and recombination protein RAD54-likeHomo sapiens (human)
protein bindingDNA repair and recombination protein RAD54-likeHomo sapiens (human)
ATP bindingDNA repair and recombination protein RAD54-likeHomo sapiens (human)
ATP hydrolysis activityDNA repair and recombination protein RAD54-likeHomo sapiens (human)
ATP-dependent DNA/DNA annealing activityDNA repair and recombination protein RAD54-likeHomo sapiens (human)
metal ion bindingDNA repair and recombination protein RAD54-likeHomo sapiens (human)
ATP-dependent chromatin remodeler activityDNA repair and recombination protein RAD54-likeHomo sapiens (human)
DNA translocase activityDNA repair and recombination protein RAD54-likeHomo sapiens (human)
protein bindingSentrin-specific protease 6Homo sapiens (human)
SUMO-specific endopeptidase activitySentrin-specific protease 6Homo sapiens (human)
protein bindingSentrin-specific protease 2Homo sapiens (human)
SUMO-specific endopeptidase activitySentrin-specific protease 2Homo sapiens (human)
deSUMOylase activitySentrin-specific protease 2Homo sapiens (human)
endopeptidase activitySentrin-specific protease 1Homo sapiens (human)
protein bindingSentrin-specific protease 1Homo sapiens (human)
deSUMOylase activitySentrin-specific protease 1Homo sapiens (human)
SUMO-specific endopeptidase activitySentrin-specific protease 1Homo sapiens (human)
protein-arginine deiminase activityProtein-arginine deiminase type-1Homo sapiens (human)
calcium ion bindingProtein-arginine deiminase type-1Homo sapiens (human)
protein-arginine deiminase activityProtein-arginine deiminase type-3Homo sapiens (human)
calcium ion bindingProtein-arginine deiminase type-3Homo sapiens (human)
protein bindingProtein-arginine deiminase type-3Homo sapiens (human)
identical protein bindingProtein-arginine deiminase type-3Homo sapiens (human)
protein-arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
calcium ion bindingProtein-arginine deiminase type-4Homo sapiens (human)
protein bindingProtein-arginine deiminase type-4Homo sapiens (human)
identical protein bindingProtein-arginine deiminase type-4Homo sapiens (human)
histone arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
histone H3R2 arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
histone H3R8 arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
histone H3R17 arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
histone H3R26 arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
protein-arginine deiminase activityProtein-arginine deiminase type-2Homo sapiens (human)
calcium ion bindingProtein-arginine deiminase type-2Homo sapiens (human)
nuclear estrogen receptor bindingProtein-arginine deiminase type-2Homo sapiens (human)
protein homodimerization activityProtein-arginine deiminase type-2Homo sapiens (human)
histone H3R26 arginine deiminase activityProtein-arginine deiminase type-2Homo sapiens (human)
histone arginine deiminase activityProtein-arginine deiminase type-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (37)

Processvia Protein(s)Taxonomy
nucleoplasmcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
plasma membranecAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
membranecAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
ruffle membranecAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
perinuclear region of cytoplasmcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
perinuclear region of cytoplasmcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
nucleuscAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
centrosomecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
synaptic vesiclecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
postsynaptic densitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
Z disccAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
dendritic spinecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
excitatory synapsecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
gamma-tubulin complexcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
voltage-gated calcium channel complexcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
nucleuscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
perinuclear region of cytoplasmcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
extracellular spacecAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
ciliumcAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
nucleuscAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
perinuclear region of cytoplasmcAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)
centrosomecAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
plasma membranecAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
apical plasma membranecAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
voltage-gated calcium channel complexcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
calcium channel complexcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
nucleuscAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
perinuclear region of cytoplasmcAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmDNA repair and recombination protein RAD54-likeHomo sapiens (human)
protein-containing complexDNA repair and recombination protein RAD54-likeHomo sapiens (human)
nucleusDNA repair and recombination protein RAD54-likeHomo sapiens (human)
nucleoplasmSentrin-specific protease 6Homo sapiens (human)
cytosolSentrin-specific protease 6Homo sapiens (human)
nucleusSentrin-specific protease 6Homo sapiens (human)
cytoplasmSentrin-specific protease 6Homo sapiens (human)
PML bodySentrin-specific protease 2Homo sapiens (human)
nucleoplasmSentrin-specific protease 2Homo sapiens (human)
cytosolSentrin-specific protease 2Homo sapiens (human)
nuclear membraneSentrin-specific protease 2Homo sapiens (human)
nuclear poreSentrin-specific protease 2Homo sapiens (human)
nucleusSentrin-specific protease 2Homo sapiens (human)
nucleoplasmSentrin-specific protease 1Homo sapiens (human)
cytoplasmSentrin-specific protease 1Homo sapiens (human)
focal adhesionSentrin-specific protease 1Homo sapiens (human)
nuclear membraneSentrin-specific protease 1Homo sapiens (human)
nucleusSentrin-specific protease 1Homo sapiens (human)
nucleoplasmProtein-arginine deiminase type-1Homo sapiens (human)
cytoplasmProtein-arginine deiminase type-1Homo sapiens (human)
cytosolProtein-arginine deiminase type-1Homo sapiens (human)
nucleusProtein-arginine deiminase type-1Homo sapiens (human)
cytoplasmProtein-arginine deiminase type-1Homo sapiens (human)
nucleoplasmProtein-arginine deiminase type-3Homo sapiens (human)
cytoplasmProtein-arginine deiminase type-3Homo sapiens (human)
cytosolProtein-arginine deiminase type-3Homo sapiens (human)
intracellular membrane-bounded organelleProtein-arginine deiminase type-3Homo sapiens (human)
nucleusProtein-arginine deiminase type-3Homo sapiens (human)
cytoplasmProtein-arginine deiminase type-3Homo sapiens (human)
nucleusProtein-arginine deiminase type-4Homo sapiens (human)
nucleoplasmProtein-arginine deiminase type-4Homo sapiens (human)
cytosolProtein-arginine deiminase type-4Homo sapiens (human)
protein-containing complexProtein-arginine deiminase type-4Homo sapiens (human)
nucleusProtein-arginine deiminase type-4Homo sapiens (human)
cytoplasmProtein-arginine deiminase type-4Homo sapiens (human)
extracellular regionProtein-arginine deiminase type-2Homo sapiens (human)
cytoplasmProtein-arginine deiminase type-2Homo sapiens (human)
cytosolProtein-arginine deiminase type-2Homo sapiens (human)
azurophil granule lumenProtein-arginine deiminase type-2Homo sapiens (human)
extracellular exosomeProtein-arginine deiminase type-2Homo sapiens (human)
euchromatinProtein-arginine deiminase type-2Homo sapiens (human)
nucleusProtein-arginine deiminase type-2Homo sapiens (human)
cytoplasmProtein-arginine deiminase type-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (128)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID495094Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse CD11b-hi neutrophils by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID200512Antimicrobial activity was determined against Salmonella gallinarum ATCC 91841987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID495076Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse B cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID336369DNA damaging activity against rad 52 DNA repair gene deficient Saccharomyces cerevisiae mutant assessed as drug level required to produce 12 mm zone of inhibition after 48 hrs1994Journal of natural products, Jan, Volume: 57, Issue:1
Isolation of bioactive and other oxoaporphine alkaloids from two annonaceous plants, Xylopia aethiopica and Miliusa cf. banacea.
AID359374DNA damaging activity against RS167N rad6 DNA repair gene deficient Saccharomyces cerevisiae mutant assessed as drug level required to produce 12 mm zone of inhibition after 48 hrs1992Journal of natural products, Nov, Volume: 55, Issue:11
Bioactive ergost-5-ene-3 beta, 7 alpha-diol derivatives from Pseudobersama mossambicensis.
AID336371DNA damaging activity against rad 6 DNA repair gene deficient Saccharomyces cerevisiae mutant assessed as drug level required to produce 12 mm zone of inhibition well after 48 hrs1994Journal of natural products, Jan, Volume: 57, Issue:1
Isolation of bioactive and other oxoaporphine alkaloids from two annonaceous plants, Xylopia aethiopica and Miliusa cf. banacea.
AID334551Induction of apoptosis in human SH-SY5Y cells assessed as nuclear accumulation of p532002Journal of natural products, May, Volume: 65, Issue:5
Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis.
AID495074Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse B cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1440268Inhibition of recombinant human IDO1 expressed in bacterial expression system at 20 uM using L-Tryptophan as substrate after 25 mins by fluorescence assay relative to control2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID495089Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1069606Competitive inhibition of recombinant wild-type PAD4 (unknown origin) at 1 to 50 uM by fluorescence polarization-ABPP assay in presence of RFA2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID164400Antimicrobial activity was determined against Pseudomonas aeruginosa ATCC 27853 cells1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID1859339Inhibition of human SENP2 using AMC-tagged SUMO1 as substrate incubated for 10 mins by fluorescence based analysis2022European journal of medicinal chemistry, Apr-05, Volume: 233Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
AID38350In vitro antibacterial activity measured against Bacillus subtilis and relative potency expressed with respect to streptonigrin.1991Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
Streptonigrin and related compounds. 5. Synthesis and evaluation of some isoquinoline analogues.
AID495092Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495066Inhibition of anisomycin-induced p38 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495100Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse CD11b-int macrophages by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID497619In vivo inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in spleen cells in BALB/c mouse at 1 to 10 mg/kg, iv administered 30 mins before IL challenge for 15 mins2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID335533DNA damaging activity against DNA repair-proficient yeast RAD+ assessed as drug concentration required to produce 12 mm zone of inhibition2002Journal of natural products, Jun, Volume: 65, Issue:6
Novel diterpene lactones from Suregada multiflora.
AID495106Inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in BALB/c mouse CD11b-int macrophages by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID38169Cytotoxicity against mouse melanoma cell culture(B-16)1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID495101Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse CD11b-int macrophages by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495080Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1813075Inhibition of PDE4 (unknown origin) by Fluopol-ABPP HTS assay2021European journal of medicinal chemistry, Dec-15, Volume: 226Peptidylarginine deiminases 4 as a promising target in drug discovery.
AID357968DNA damaging activity against topoisomerase 2-deficient RS321N mutant yeast assessed as drug level required to produce 12 mm zone of inhibition by agar well diffusion assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica.
AID495069Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse B cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1069622Inhibition of recombinant wild-type PAD1 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by substrate addition measured after 15 mins by COLDER assay2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID202509In vitro cytotoxic activity against SK-OV-3 (ovarian) using SRB (sulforhodamine B) assay1999Bioorganic & medicinal chemistry letters, Apr-19, Volume: 9, Issue:8
Synthesis and cytotoxic activities of 6-chloro-7-arylamino-5,8-isoquinolinediones.
AID495096Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse CD11b-hi neutrophils by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495093Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse CD11b-hi neutrophils by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID144440Antimicrobial activity was determined against Mycobacterium smegmatis ATCC 6071987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID497617In vivo inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in blood cells in BALB/c mouse at 1 to 10 mg/kg, iv administered 30 mins before IL challenge for 15 mins2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID392156Inhibition of Cryptosporidium hominis TS-DHFR by spectroscopic assay2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen.
AID1859340Inhibition of human SENP6 using AMC-tagged SUMO1 as substrate incubated for 10 mins by fluorescence based analysis2022European journal of medicinal chemistry, Apr-05, Volume: 233Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
AID497615Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in BALB/c mouse B cells at 3.5 uM by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495083Inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID26051The dissociation constant at pH 3 using potentiometric titration in 100 uM of compound in 0.15 M KCl at 25 degrees Centigrade1989Journal of medicinal chemistry, Jul, Volume: 32, Issue:7
Bifunctional antitumor compounds: synthesis and characterization of a Au(III)-streptonigrin complex with thiol-modulating properties.
AID1859338Inhibition of human SENP1 using AMC-tagged SUMO1 as substrate incubated for 10 mins by fluorescence based analysis2022European journal of medicinal chemistry, Apr-05, Volume: 233Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
AID7805Metabolism by recombinant human NAD(P)H:quinone oxidoreductase (NQO1) was evaluated1999Bioorganic & medicinal chemistry letters, Aug-02, Volume: 9, Issue:15
Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
AID424680Cytotoxicity against CD30 expressing and CD70 deficient human L540cy cells after 96 hrs by resazurin conversion assay2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.
AID1069621Inhibition of recombinant wild-type PAD2 (unknown origin) using N-alpha-Benzoyl-L-arginine ethyl ester as substrate preincubated for 15 mins followed by substrate addition measured after 15 mins by COLDER assay2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID1069602Binding affinity to PAD2 C647A mutant (unknown origin) assessed as mass shift of enzyme at 1:10 enzyme to compound ratio preincubated for 1 hr followed by overnight dialysis in double distilled water by MALDI mass spectrometric analysis2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID495073Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse B cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID26054The dissociation constant of the free compound in 1: 1 dioxane-water mixture.1989Journal of medicinal chemistry, Jul, Volume: 32, Issue:7
Bifunctional antitumor compounds: synthesis and characterization of a Au(III)-streptonigrin complex with thiol-modulating properties.
AID409957Inhibition of bovine liver MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID495097Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse CD11b-hi neutrophils by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID497620In vivo inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in spleen cells in BALB/c mouse at 1 to 10 mg/kg, iv administered 30 mins before IL challenge for 15 mins2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495095Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in BALB/c mouse CD11b-hi neutrophils by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID44988Antimicrobial activity was determined against Candida albicans ATCC 102311987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID495090Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495072Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse B cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID201799In vitro cytotoxic activity against SK-MEL-2 (melanoma) using SRB (sulforhodamine B) assay1999Bioorganic & medicinal chemistry letters, Apr-19, Volume: 9, Issue:8
Synthesis and cytotoxic activities of 6-chloro-7-arylamino-5,8-isoquinolinediones.
AID495082Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID38351Antibacterial activity against Bacillus subtilis and values were expressed as standard error for slope1991Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
Streptonigrin and related compounds. 5. Synthesis and evaluation of some isoquinoline analogues.
AID495104Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse CD11b-int macrophages by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID334547Cytotoxicity against human SH-SY5Y cells overexpressing dominant negative mutant of p532002Journal of natural products, May, Volume: 65, Issue:5
Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis.
AID497618In vivo inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in blood cells in BALB/c mouse at 1 to 10 mg/kg, iv administered 30 mins before IL challenge for 15 mins2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1069600Binding affinity to recombinant wild-type PAD4 (unknown origin) assessed as mass shift of enzyme at 1:10 enzyme to compound ratio preincubated for 1 hr followed by overnight dialysis in double distilled water by MALDI mass spectrometric analysis in presen2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID495071Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in BALB/c mouse B cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495088Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID424679Cytotoxicity against CD30 expressing and CD70 deficient human KARPAS299 cells after 96 hrs by resazurin conversion assay2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.
AID1069604Binding affinity to recombinant wild-type PAD4 (unknown origin) assessed as mass shift of enzyme at 1:10 enzyme to compound ratio preincubated for 1 hr followed by overnight dialysis in double distilled water by MALDI mass spectrometric analysis2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID1069603Binding affinity to recombinant wild-type PAD2 (unknown origin) assessed as mass shift of enzyme at 1:10 enzyme to compound ratio preincubated for 1 hr followed by overnight dialysis in double distilled water by MALDI mass spectrometric analysis2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID495064Inhibition of JAK-mediated GM-CSF-induced Stat5 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495078Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID402547DNA damaging activity against RS 321N Saccharomyces cerevisiae2004Journal of natural products, May, Volume: 67, Issue:5
Further bioactive piperidine alkaloids from the flowers and green fruits of Cassia spectabilis.
AID355286DNA damaging activity against wild-type Saccharomyces cerevisiae assessed as drug level required to produce 12 mm zone of inhibition assessed per 100 uL after 48 hrs1997Journal of natural products, Oct, Volume: 60, Issue:10
Three new pseudodistomins, piperidine alkaloids from the ascidian Pseudodistoma megalarva.
AID495075Inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in BALB/c mouse B cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495099Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse CD11b-hi neutrophils by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID336370DNA damaging activity against rad 52 DNA repair gene/topoisomerase 1 deficient Saccharomyces cerevisiae mutant assessed as drug level required to produce 12 mm zone of inhibition well after 48 hrs1994Journal of natural products, Jan, Volume: 57, Issue:1
Isolation of bioactive and other oxoaporphine alkaloids from two annonaceous plants, Xylopia aethiopica and Miliusa cf. banacea.
AID495098Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse CD11b-hi neutrophils by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1069597Binding affinity to PAD4 C645A mutant (unknown origin) assessed as mass shift of enzyme at 1:10 enzyme to compound ratio preincubated for 1 hr followed by overnight dialysis in double distilled water by MALDI mass spectrometric analysis in presence of cat2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID1868247Inhibition of SENP1 (unknown origin) using AMC-tagged SUMO1 as fluorogenic substrate preincubated for 10 mins followed by substrate addition and measured after 15 mins by fluorescence assay2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID495105Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse CD11b-int macrophages by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID334546Cytotoxicity against human wild type SH-SY5Y cells2002Journal of natural products, May, Volume: 65, Issue:5
Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1069598Binding affinity to recombinant wild-type PAD4 (unknown origin) assessed as mass shift of enzyme at 1:10 enzyme to compound ratio preincubated for 1 hr followed by overnight dialysis in double distilled water by MALDI mass spectrometric analysis in presen2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID78628In vitro cytotoxic activity against HCT-15 (colon) using SRB (sulforhodamine B) assay1999Bioorganic & medicinal chemistry letters, Apr-19, Volume: 9, Issue:8
Synthesis and cytotoxic activities of 6-chloro-7-arylamino-5,8-isoquinolinediones.
AID207620Antimicrobial activity was determined against Staphylococcus aureus ATCC 137091987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID1069599Binding affinity to PAD4 C645A mutant (unknown origin) assessed as mass shift of enzyme at 1:10 enzyme to compound ratio preincubated for 1 hr followed by overnight dialysis in double distilled water by MALDI mass spectrometric analysis in presence of sup2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID357969DNA damaging activity against topoisomerase 2-deficient rad52Y mutant yeast assessed as drug level required to produce 12 mm zone of inhibition by agar well diffusion assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica.
AID1069607Competitive inhibition of recombinant wild-type PAD2 (unknown origin) at 0.1 to 2.5 uM by fluorescence polarization-ABPP assay in presence of RFA2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID334548Selectivity ratio of IC50 for human SH-SY5Y cells overexpressing dominant negative mutant of p53 to IC50 for human wild type SH-SY5Y cells2002Journal of natural products, May, Volume: 65, Issue:5
Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis.
AID8638In vitro cytotoxic activity against A 549 (non-small cell lung) using SRB (sulforhodamine B) assay1999Bioorganic & medicinal chemistry letters, Apr-19, Volume: 9, Issue:8
Synthesis and cytotoxic activities of 6-chloro-7-arylamino-5,8-isoquinolinediones.
AID95768In vitro root inhibition activity measured using seedlings of Lepidium sativum, and relative potency expressed with respect to streptonigrin.1991Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
Streptonigrin and related compounds. 5. Synthesis and evaluation of some isoquinoline analogues.
AID495320Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse CD11b-int macrophages by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495085Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID359373DNA damaging activity against RS322YK rad52 DNA repair gene deficient Saccharomyces cerevisiae mutant assessed as drug level required to produce 12 mm zone of inhibition after 48 hrs1992Journal of natural products, Nov, Volume: 55, Issue:11
Bioactive ergost-5-ene-3 beta, 7 alpha-diol derivatives from Pseudobersama mossambicensis.
AID355287DNA damaging activity against RAD52 DNA repair gene deficient Saccharomyces cerevisiae mutant assessed as drug level required to produce 12 mm zone of inhibition assessed per 100 uL after 48 hrs1997Journal of natural products, Oct, Volume: 60, Issue:10
Three new pseudodistomins, piperidine alkaloids from the ascidian Pseudodistoma megalarva.
AID94910Cytotoxicity against mouse lymphoblastic leukemia cell culture (L-1210)1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID69959Antimicrobial activity was determined against Escherichia coli ATCC 96371987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID152700Cytotoxicity against P388 mouse leukemia cell culture (9PS(P388))1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID495065Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1069601Binding affinity to PAD4 C645A mutant (unknown origin) assessed as mass shift of enzyme at 1:10 enzyme to compound ratio preincubated for 1 hr followed by overnight dialysis in double distilled water by MALDI mass spectrometric analysis2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID335532DNA damaging activity against DNA repair-deficient yeast RAD52 mutant assessed as drug concentration required to produce 12 mm zone of inhibition2002Journal of natural products, Jun, Volume: 65, Issue:6
Novel diterpene lactones from Suregada multiflora.
AID219584In vitro cytotoxic activity against XF 498 (CNS) using SRB (sulforhodamine B) assay1999Bioorganic & medicinal chemistry letters, Apr-19, Volume: 9, Issue:8
Synthesis and cytotoxic activities of 6-chloro-7-arylamino-5,8-isoquinolinediones.
AID495103Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse CD11b-int macrophages by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495084Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1069619Inhibition of recombinant wild-type PAD4 (unknown origin) using N-alpha-Benzoyl-L-arginine ethyl ester as substrate preincubated for 15 mins followed by substrate addition measured after 15 mins by COLDER assay2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID336372DNA damaging activity against wild type Saccharomyces cerevisiae expressing rad DNA repair gene assessed as drug level required to produce 12 mm zone of inhibition after 48 hrs1994Journal of natural products, Jan, Volume: 57, Issue:1
Isolation of bioactive and other oxoaporphine alkaloids from two annonaceous plants, Xylopia aethiopica and Miliusa cf. banacea.
AID38352In vitro antibacterial activity against Bacillus subtilis1991Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
Streptonigrin and related compounds. 5. Synthesis and evaluation of some isoquinoline analogues.
AID355289DNA damaging activity against RAD52 DNA repair gene/topoisomerase 1 deficient Saccharomyces cerevisiae GAL4:RAD52 mutant assessed as drug level required to produce 12 mm zone of inhibition assessed per 100 uL in galactose medium after 48 hrs1997Journal of natural products, Oct, Volume: 60, Issue:10
Three new pseudodistomins, piperidine alkaloids from the ascidian Pseudodistoma megalarva.
AID44019Cytotoxicity against human lymphoblastic leukemia cell culture (CCRF-CEM)1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID424681Cytotoxicity against CD30 deficient and CD70 expressing human Caki1 cells after 96 hrs by resazurin conversion assay2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.
AID355288DNA damaging activity against RAD52 DNA repair gene/topoisomerase 1 deficient Saccharomyces cerevisiae GAL4:RAD52 mutant assessed as drug level required to produce 12 mm zone of inhibition assessed per 100 uL in glucose medium after 48 hrs1997Journal of natural products, Oct, Volume: 60, Issue:10
Three new pseudodistomins, piperidine alkaloids from the ascidian Pseudodistoma megalarva.
AID495070Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse B cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495079Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID95767In vitro root inhibition activity using seedlings of Lepidium sativum1991Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
Streptonigrin and related compounds. 5. Synthesis and evaluation of some isoquinoline analogues.
AID495102Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in BALB/c mouse CD11b-int macrophages by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID334552Induction of apoptosis in human SH-SY5Y cells assessed as DNA ladder activity2002Journal of natural products, May, Volume: 65, Issue:5
Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis.
AID495077Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
AID495086Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID497616Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in BALB/c mouse CD4+ T cells at 100 uM by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID495081Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID26052The dissociation constant at pH 8 using potentiometric titration in 100 uM of compound in 0.15 M KCl at 25 degree Centigrade1989Journal of medicinal chemistry, Jul, Volume: 32, Issue:7
Bifunctional antitumor compounds: synthesis and characterization of a Au(III)-streptonigrin complex with thiol-modulating properties.
AID94298Antimicrobial activity was determined against Klebsiella pneumoniae ATCC 100311987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID1178414Inhibition of RAD54 (unknown origin) ATPase activity assessed as generation of reactive oxygen species2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Targeting the homologous recombination pathway by small molecule modulators.
AID70061Cytotoxicity against human epidermoid carcinoma of the nasopharynx (9KB)1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
AID1069620Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by substrate addition measured after 15 mins by COLDER assay2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
AID495091Inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID152449Compound concentration was evaluated in vitro to inhibit the growth of P-388 leukemia cells1989Journal of medicinal chemistry, Jul, Volume: 32, Issue:7
Bifunctional antitumor compounds: synthesis and characterization of a Au(III)-streptonigrin complex with thiol-modulating properties.
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (386)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990210 (54.40)18.7374
1990's65 (16.84)18.2507
2000's54 (13.99)29.6817
2010's44 (11.40)24.3611
2020's13 (3.37)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.54 (24.57)
Research Supply Index6.01 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (1.75%)5.53%
Reviews34 (8.52%)6.00%
Case Studies2 (0.50%)4.05%
Observational0 (0.00%)0.25%
Other356 (89.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]